hotspot -WSS

hotspot

author：fashion 2025-08-26 23:46:36 - browse：5227

ANDREW YATES/AFP via Getty Images

In patients with stage 3 lung cancer where a particular genetic mutation is present in the tumor, taking AstraZeneca’s cancer-fighting pill Tagrisso reduced the chance that disease would progress by 84%.

“This will be practice changing as soon as this becomes available,” said David R. Spigel, chief scientific officer of the Sarah Cannon Research Institute at a press conference announcing the results at the annual meeting of the American Society of Clinical Oncology. “This will be how patients are treated wherever they can get access to this drug.”

Spigel but was not involved in the Tagrisso study but has relationships with multiple drugmakers including AstraZeneca.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： The drug industry sees a key ally in the Senate prevail

WSS

What Mike Pence has said that could be used in a Donald Trump trial

'Cuddling' is just what the doctor ordered for a 200

My superpower is killing ticks

For BCIs, commercial hurdles may be bigger than scientific ones

Microsoft strikes partnership with Duke Health to advance health AI

TytoCare raises $49 million to build out AI

hotspot

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

knowledge

In Memoriam: Notable people who died in 2023

Dramatically reducing cancer deaths requires the PASTEUR Act

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Eat, drink, but be wary — 4 foods that interact with medications

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Nearly two

Dobbs anniversary: the lost opportunity of abortion as health care

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The drug industry sees a key ally in the Senate prevail

focus

ER docs worry over extreme heat as a 'mass casualty event'

What the cancer research community can learn from the Covid response

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

ProMED, early warning system on disease outbreaks, in peril

Russian court extends detention of American musician

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

leisure time

entertainment

hotspot

focus